80 FR 60149 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Initial review

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 80, Issue 192 (October 5, 2015)

[Federal Register Volume 80, Number 192 (Monday, October 5, 2015)]
[Notices]
[Page 60149]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-25274]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel: Initial review

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces a meeting for the initial review of 
applications in response to Funding Opportunity Announcement (FOA) 
PS16-001, Minority HIV/AIDS Research Initiative (MARI) to Build HIV 
Prevention Treatment and Research Capacity in Disproportionately 
Affected Black and Hispanic Communities and Among Historically 
Underrepresented Researchers.

DATES: 10:00 a.m.-5:00 p.m., December 9-10, 2015 (Closed).

ADDRESSES: Teleconference.

FOR FURTHER INFORMATION CONTACT: Gregory Anderson, M.S., M.P.H., 
Scientific Review Officer, National Center for HIV/AIDS, Viral 
Hepatitis, STD, and TB Prevention (NCHHSTP), CDC, 1600 Clifton Road 
NE., Mailstop E60, Atlanta, Georgia 30333, Telephone: (404) 718-8833.

SUPPLEMENTARY INFORMATION: 
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and 
the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters for Discussion: The meeting will include the initial 
review, discussion, and evaluation of applications received in response 
to ``Minority HIV/AIDS Research Initiative (MARI) to Build HIV 
Prevention Treatment and Research Capacity in Disproportionately 
Affected Black and Hispanic Communities and Among Historically 
Underrepresented Researchers'', FOA PS16-001.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2015-25274 Filed 10-2-15; 8:45 am]
 BILLING CODE 4163-18-P